Nuvaira: Revolutionary therapy that blasts 80°C radiofrequency into defective lung nerves could help thousands of sufferers with severe asthma

posted on 06 Jun 2019

Nuvaira deploys a ground-breaking therapy called targeted lung denervation. It’s based on the discovery that a faulty nerve that runs from the brain to the lungs may be partly to blame for asthma flare-ups.

For many years, the illness was thought to be due solely to the immune system overreacting to allergens – such as pollen – or viruses, like a cold. But scientists now know it can also be worsened by problems with the vagus nerve – a twisting bundle of pathways running from the chest to the brain.

Branches of the vagus nerve control the muscles in the airways that manage the breathing. In healthy lungs, the nerve sends signals to the muscles to ensure they contract and relax smoothly, allowing the airways to inhale and exhale properly.

But if the nerves are faulty, these muscles become overactive. As they tighten more and relax less, the airways become narrowed and breathing becomes harder. Destroying these branches of the vagus nerve blocks the faulty signals, stopping the muscles in the airways from tightening and allowing more air to pass into the lungs.

Denervation involves the patient being given a general anaesthetic and a device called a bronchoscope being inserted through the mouth and into the lungs.

[Nuvaira] has already proved successful in treating patients who suffer from chronic obstructive pulmonary disorder – a severe breathing problem often, but not always, caused by smoking.

Now 30 asthma patients at hospitals in the UK, France, Germany, and the Netherlands, including some treated on the NHS, will receive the therapy as part of a three-year clinical trial.

For more details, please see the article on DailyMail UK here


Recent posts

Geek+ powers remote operations & new deployments for Decathlon in China

Geek+, a global AMR leader is pleased to announce it has extended its cooperation with Decathlon, one of the world's largest retailers of sporting goods, present in over 50 countries with more than 1,600 stores globally. Following the success of a two-year collaboration in its e-commerce and retail fulfillment centers in Shanghai, Decathlon accelerated its automation program, with AMR deployments at two new sites in China. The installations were successfully deployed remotely in under 3 months, following strict pandemic restrictions.

06 Jun 2019
Read more

Geek+ Helps Streamline Winit's Warehouse Operations

Geek+, a global AMR leader, announces its commitment to provide smart logistics solutions for enabling efficient and flexible operations to Winit, an integrated supply chain solutions provider for cross-border e-commerce serving industry leaders like eBay, for its fulfillment center located Cincinnati, Ohio.

Rick DeFiesta, Director of Business Development and Partnership at Geek+, said: "We are pleased that Winit has chosen our Goods-to-Person solution for optimizing their warehouse operations and we are confident that our P-series robots will exceed expectation to increase picking efficiency, simplify processes, and reduce management issues."

06 Jun 2019
Read more

Bicycle Therapeutics Appoints Sir Keith Peters as Chairman of Its Scientific Advisory Board

“Sir Keith is a world-renowned expert in the field of clinical immunology and has made significant contributions to the development of new medicines by applying a better understanding of physiology to the development of novel therapies,” said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics.

06 Jun 2019
Read more

Quick Links

    Our Global Network

    Vertex Growth is part of a global network of venture capital funds, which includes Vertex Ventures and Vertex Ventures HC.

    The funds are based across global innovation hubs in China, Israel, Southeast Asia and India, and the US. This creates a unique platform for our portfolio companies to realize their full potential by leveraging the combined experience and resources of our extensive network of global partners.


    © 2019 by Vertex.

    All rights reserved.